BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,920 | -18.9% | 103,917 | -2.1% | 0.05% | -13.8% |
| Q2 2023 | $4,833 | +71.5% | 106,107 | +52.7% | 0.06% | +75.8% |
| Q1 2023 | $2,818 | -21.6% | 69,489 | -1.5% | 0.03% | -26.7% |
| Q4 2022 | $3,596 | -99.9% | 70,565 | +0.9% | 0.04% | -11.8% |
| Q3 2022 | $3,766,000 | -18.9% | 69,925 | -3.3% | 0.05% | -10.5% |
| Q2 2022 | $4,646,000 | -65.3% | 72,345 | -58.1% | 0.06% | -59.6% |
| Q1 2022 | $13,387,000 | -16.6% | 172,659 | -7.6% | 0.14% | -9.0% |
| Q4 2021 | $16,047,000 | -3.9% | 186,959 | -10.0% | 0.16% | -7.7% |
| Q3 2021 | $16,701,000 | -5.0% | 207,664 | -4.9% | 0.17% | -5.6% |
| Q2 2021 | $17,584,000 | -19.6% | 218,451 | -15.8% | 0.18% | -25.2% |
| Q1 2021 | $21,878,000 | -3.1% | 259,421 | -7.8% | 0.24% | -7.0% |
| Q4 2020 | $22,577,000 | -15.5% | 281,389 | -15.3% | 0.26% | -22.2% |
| Q3 2020 | $26,706,000 | +107.2% | 332,099 | +121.8% | 0.33% | +99.4% |
| Q2 2020 | $12,890,000 | -3.1% | 149,725 | -8.7% | 0.16% | -21.4% |
| Q1 2020 | $13,308,000 | +3.9% | 163,936 | +7.0% | 0.21% | +25.7% |
| Q4 2019 | $12,809,000 | -3.8% | 153,193 | +0.6% | 0.17% | -7.2% |
| Q3 2019 | $13,320,000 | +92.0% | 152,302 | +79.7% | 0.18% | +53.8% |
| Q2 2019 | $6,939,000 | -13.6% | 84,748 | -14.2% | 0.12% | -17.6% |
| Q1 2019 | $8,033,000 | +7.4% | 98,826 | -13.1% | 0.14% | -1.4% |
| Q4 2018 | $7,482,000 | -9.2% | 113,714 | +6.3% | 0.14% | +3.6% |
| Q3 2018 | $8,241,000 | +5.9% | 106,932 | +1.4% | 0.14% | 0.0% |
| Q2 2018 | $7,781,000 | +24.9% | 105,426 | +10.0% | 0.14% | +6.9% |
| Q1 2018 | $6,232,000 | +13.7% | 95,856 | +13.0% | 0.13% | -0.8% |
| Q4 2017 | $5,481,000 | +109.4% | 84,820 | +103.3% | 0.13% | -1.5% |
| Q3 2017 | $2,617,000 | +87.2% | 41,731 | +80.6% | 0.13% | +40.0% |
| Q2 2017 | $1,398,000 | +22.2% | 23,111 | +4.6% | 0.10% | +14.5% |
| Q1 2017 | $1,144,000 | +427.2% | 22,092 | +350.7% | 0.08% | +295.2% |
| Q4 2016 | $217,000 | -94.4% | 4,902 | -94.0% | 0.02% | -94.8% |
| Q3 2016 | $3,862,000 | +11.7% | 81,142 | +6.1% | 0.40% | +12.2% |
| Q2 2016 | $3,457,000 | +17.7% | 76,463 | +6.9% | 0.36% | +18.0% |
| Q1 2016 | $2,938,000 | +271.4% | 71,539 | +244.8% | 0.30% | +174.8% |
| Q4 2015 | $791,000 | +37.6% | 20,749 | +18.4% | 0.11% | -11.9% |
| Q3 2015 | $575,000 | -39.5% | 17,525 | +28.8% | 0.13% | -38.8% |
| Q2 2015 | $951,000 | +2.1% | 13,605 | 0.0% | 0.21% | +10.2% |
| Q1 2015 | $931,000 | +52.6% | 13,605 | +63.2% | 0.19% | +48.4% |
| Q4 2014 | $610,000 | -51.1% | 8,335 | -52.1% | 0.13% | -55.6% |
| Q3 2014 | $1,248,000 | +97.5% | 17,395 | +98.7% | 0.28% | +121.9% |
| Q2 2014 | $632,000 | +2.9% | 8,755 | +4.8% | 0.13% | -3.0% |
| Q1 2014 | $614,000 | -61.3% | 8,355 | -63.4% | 0.13% | -63.8% |
| Q4 2013 | $1,588,000 | +25.5% | 22,835 | +18.5% | 0.36% | +22.9% |
| Q3 2013 | $1,265,000 | -3.9% | 19,265 | +1.3% | 0.30% | -14.4% |
| Q2 2013 | $1,317,000 | – | 19,015 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |